PTGS2 and major depressive disorder: Other potential mechanisms of COX-2 inhibitors therapeutic effects may involve their ability to reduce proinflammatory cytokine levels [163], limit quinolinic acid excitotoxicity (as in MDD) and decrease KYNA levels (as in schizophrenia) [128].